ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Yuan Liu
Matched on ORCID iD 0009-0007-0579-4056; OpenAlex author ID A5100390972. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2023: 1 paper · 2024: 2 papers
Papers 3
- Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.csbj.2024.04.021↗
- NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation. Co-author DOI 10.1186/s12885-024-11842-5↗
- Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response. Co-author DOI 10.1016/j.xcrm.2023.101234↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qingcai Meng · 3 shared papers, 2023–2024 · strength 0.57
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Rong Tang · 3 shared papers, 2023–2024 · strength 0.57
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Jin Xu · 3 shared papers, 2023–2024 · strength 0.57
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Xianjun Yu · 3 shared papers, 2023–2024 · strength 0.57
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Si Shi · 3 shared papers, 2023–2024 · strength 0.57
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Bo Zhang · 2 shared papers, 2023–2024 · strength 0.38
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Wei Wang · 2 shared papers, 2023–2024 · strength 0.38
- Paper NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduce… DOI 10.1186/s12885-024-11842-5↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Jie Hua · 2 shared papers, 2023–2024 · strength 0.34
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Chen Liang · 2 shared papers, 2023–2024 · strength 0.34
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Qiong Du · 2 shared papers, 2023–2024 · strength 0.34
- Paper Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancr… DOI 10.1016/j.csbj.2024.04.021↗
- Paper Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity an… DOI 10.1016/j.xcrm.2023.101234↗
- Bo Zhang · 1 shared paper, 2024 · strength 0.20
- Wei J. Wang · 1 shared paper, 2024 · strength 0.20
- Di Wu · 1 shared paper, 2023 · strength 0.15
- Yiyin Zhang · 1 shared paper, 2023 · strength 0.15
- Chenghao Shao · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.